Hypoglycemia Associated With Drug–Drug Interactions in Patients With Type 2 Diabetes Mellitus Using Dipeptidylpeptidase-4 Inhibitors

Hypoglycemia Associated With Drug–Drug Interactions in Patients With Type 2 Diabetes Mellitus Using Dipeptidylpeptidase-4 Inhibitors

Background: Dipeptidylpeptidase-4 inhibitors (DPP-4i′s) are considered to be safe for patients with type 2 diabetes mellitus (T2DM). However, little is known about drug–drug interactions between DPP-4i′s and concurrent medications.Methods: Data on patients using DPP-4i′s for T2DM during 2011–2017 we...

Full description

Bibliographic Details
Main Authors: Chin-Ying Ray, Victor Chien-Chia Wu, Chun-Li Wang, Hui-Tzu Tu, Yu-Tung Huang, Chang-Fu Kuo, Shang-Hung Chang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Pharmacology
Subjects:
dipeptidylpeptidase-4 inhibitors
drug-drug interaction
drug safety
hypoglycemia
diabetes mellifus
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.570835/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.570835/full

Similar Items